AYURVEDIC MANAGEMENT OF CERVICAL SPONDYLOSIS WITH VATAGAJANKUSH RAS AND NASYA: A SINGLE CASE STUDY
Sanjeevani Darshan - National Journal of Ayurveda & Yoga · 2026 · 04 (02) · 01-10
DOI: 10.55552/sdnjay.2026.4201 ↗Kurz gefasst
Fachartikel in der Zeitschrift Sanjeevani Darshan - National Journal of Ayurveda & Yoga, 2026. Verfasst von Dr. Prerna Masatkar und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Cervical spondylosis is a degenerative condition of the cervical spine commonly seen in middle-aged individuals, characterized by neck stiffness, pain, and sometimes neurological deficits. In Ayurveda, it can be correlated with Greeva Graha, a Vata-dominant disorder affecting the cervical region. This case study evaluates the efficacy of Vatagajankush Rath and Nasty Karma in the management of cervical spondylosis. A 42-year-old female presented with complaints of chronic neck pain and stiffness visited hospital for treatment. After 21 days of Ayurvedic intervention, the patient reported significant improvement in symptoms without adverse effects. This suggests that an integrative Ayurvedic approach can effectively manage Vata-vyadhi, like cervical spondylosis.
Zitieren
APA
Masatkar, D. P., & Dachewar, D. A. S. (2026). AYURVEDIC MANAGEMENT OF CERVICAL SPONDYLOSIS WITH VATAGAJANKUSH RAS AND NASYA: A SINGLE CASE STUDY. Sanjeevani Darshan - National Journal of Ayurveda & Yoga, 04(02), 01-10. https://doi.org/10.55552/sdnjay.2026.4201
Vancouver
Masatkar DP, Dachewar DAS. AYURVEDIC MANAGEMENT OF CERVICAL SPONDYLOSIS WITH VATAGAJANKUSH RAS AND NASYA: A SINGLE CASE STUDY. Sanjeevani Darshan - National Journal of Ayurveda & Yoga. 2026;04(02):01-10. doi:10.55552/sdnjay.2026.4201
BibTeX
@article{Masatkar2026,
author = {Masatkar, Dr. Prerna and Dachewar, Dr Archana S.},
title = {AYURVEDIC MANAGEMENT OF CERVICAL SPONDYLOSIS WITH VATAGAJANKUSH RAS AND NASYA: A SINGLE CASE STUDY},
journal = {Sanjeevani Darshan - National Journal of Ayurveda & Yoga},
year = {2026},
volume = {04},
number = {02},
pages = {01--10},
doi = {10.55552/sdnjay.2026.4201}
}
EUVIMED